Best PET-CT with Gallium 68(PSMA) Doctors Worldwide — TOP 96

Professor Bulent Karagoz is a medical oncologist at Anadolu Medical Center. He specializes in treating complex solid tumors and blood cancers using PET-CT with Gallium 68(PSMA) for diagnostic staging.

• Former Head of Internal Diseases and Medical Oncology at Istanbul Okan University
• Authored 40+ scientific publications focusing on tumor biology and cancer research
• Expert in neuroendocrine tumors and targeted therapies for advanced-stage cancers
• Member of the European Head and Neck Society
• Trained in tumor biology at the Medical Oncology Association

Dr. Bugra Cetin is a board-certified urological surgeon at Uroaesthetic in Istanbul. He specializes in penile prosthesis surgery, genital reconstruction, and male sexual health. Dr. Cetin has performed hundreds of successful penile implant and reconstructive procedures. He holds a PhD in Molecular Medicine and acts as a Rigicon Global Reference Center specialist.

• Member of the International and European Societies for Sexual Medicine.
• Treats erectile dysfunction, Peyronie’s disease, and complex urethral strictures.
• Uses microsurgical and endoscopic techniques for varicocelectomy and bladder procedures.
• Works at Uroaesthetic, a clinic holding ISO and European Board of Urology certifications.

Dr. Kezban Berberoglu is a professor of nuclear medicine at Anadolu Medical Center in Istanbul. She completed training at the Johns Hopkins University School of Medicine in Baltimore. Dr. Berberoglu specializes in nuclear oncology and nuclear cardiology. She treats thyroid and prostate cancers using radioisotope therapies. She is a member of the European Association of Nuclear Medicine.

• Performs Lutetium-177 and Actinium-225 therapies for oncology patients.
• Expert in PET-CT imaging using Gallium 68 for oncology cases.
• Member of the Turkish Nuclear Medicine Association cardiology work group.
• Works at an MTQUA Top 10 world hospital affiliated with Johns Hopkins.

Dr. Tinay is an executive board member of the Association of Urooncology. He uses Gallium 68 PSMA PET-CT to stage urological cancers with high precision.

• Spearheads bladder cancer research as Secretary of the Bladder Tumors Research Group
• Fellow of the American College of Surgeons – a world-recognized surgical body
• Specializes in urological biomarkers to improve the accuracy of cancer detection
• Won the Urooncology Association Scientific Research Award for his clinical work
• Member of the European Association of Urology and International Bladder Cancer Network

Dr. Cenk Acar is a urological surgeon at Hisar Hospital Intercontinental in Istanbul. He has performed over 500 surgeries for urological cancers. He was the first doctor in Turkey to apply bipolar prostate enucleation. Dr. Acar completed a fellowship in robotic and laparoscopic surgery at The Netherlands Cancer Institute.

• Performed over 250 HOLEP procedures for benign prostate enlargement.
• Expert in intraoperative fluorescence imaging for robotic urological surgeries.
• Specializes in sentinel lymph node dissections for prostate cancer treatment.
• Works at a JCI-accredited hospital serving 500,000 patients annually.

Professor Christoph Zielinski is the chairman of the Vienna Cancer Center and a leading expert in oncology. He uses advanced tools like Gallium 68 PSMA PET-CT to personalize cancer care.

• Medical Director of the International Oncology Center at Wiener Privatklinik
• Founder and former director of the Comprehensive Cancer Center Vienna
• Published over 600 scientific papers on cancer biology and targeted drugs
• Former president of the Central European Cooperative Oncology Group
• Member of the American Society of Clinical Oncology since the 1990s

Dr. Tunc Ozdemir is the Head of Urology at Istanbul Florence Nightingale Hospital. He performed Turkey’s first robotic sacrocolpopexy operations. Dr. Ozdemir helped establish the first robotic urologic surgery program in the country. He focuses on uro-oncology, specifically prostate cancer and kidney tumor treatment.

• Professor of Urology at Bilim University with fellowship training at the European Oncology Center.
• Winner of the Karl Storz Second Prize for robotic prostatectomy research.
• Received the Best Video Presentation Award at the Istanbul Robotic Urology Symposium.
• Specializes in Da Vinci prostatectomy, HIFU treatment, and laser prostate surgery.

Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.

• Served as the Head of the Hematology Division at Tel Aviv University.
• Treats complex cases of leukemia, lymphoma, and rare pediatric cancers.
• Member of the American Society of Hematology and European Group for Blood and Marrow Transplantation.
• Collaborates on research with the NIH and St. Jude Children’s Research Hospital.

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Mehmet Sarier is a urologist and andrologist at Medical Park Antalya Hospital. He serves as a faculty member at Istinye University Faculty of Medicine. Dr. Sarier specializes in male infertility, sexual health, and robotic surgery. He holds the rank of associate professor since 2020.

• Performs robotic da Vinci prostatectomy and nephrectomy.
• Uses stem cell therapy to treat erectile dysfunction and male infertility.
• Treats complex conditions like varicocele, azoospermia, and Peyronie's disease.
• Practices at the largest private hospital in the Mediterranean region.

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Dr. Barak Rosenzweig directs the Urological Oncology Service at Sheba Medical Center in Israel. He is a surgeon who has been listed among Israel’s Best Doctors by Forbes. Dr. Rosenzweig specializes in treating tumors of the prostate, kidney, bladder, and testis. He focuses on robotic and minimally invasive cancer surgery to preserve organ function.

• Completed a Urological Oncology fellowship at Memorial Sloan Kettering Cancer Center.
• Performs robotic radical prostatectomy and kidney-sparing partial nephrectomy.
• Clinical Senior Lecturer at Tel Aviv University with over 200 scientific publications.
• Uses MRI-guided fusion biopsy for high-precision prostate cancer detection.

Dr. Murat Savas is a professor of urology at Medical Park Antalya Hospital Complex. He specializes in laparoscopic and robotic surgery for complex prostate and kidney conditions. Dr. Savas completed a prestigious urology fellowship at Charité Hospital in Berlin. He holds multiple certifications in laparoscopic surgery from the Endourology Association and IRCAD.

• Performs robotic da Vinci prostatectomy and nephrectomy.
• Winner of the Best Video Award from the National Urology Congress.
• Uses Holmium Laser Enucleation for benign prostatic hyperplasia (BPH).
• Certified in urodynamics, neuro-uropharmacology, and microsurgical varicocele techniques.

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Dr. Dai Haiyan is the President and Chief Physician of Gynecology at Shanghai Tongji Hospital. He holds a Level IV certification in laparoscopic surgery. This is the highest proficiency level for minimally invasive procedures. Dr. Dai completed specialized training at the University of Oslo Cancer Hospital in Norway.

• Expert in uterus-preserving treatment for endometriosis and complex gynecological conditions.
• Performs pelvic floor reconstruction and vaginal reconstructive surgery.
• Mentors graduate students as a Master’s Supervisor at Fudan University.
• Specializes in hysteroscopic and laparoscopic minimally invasive techniques.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental. He performed an advanced fellowship at the University of Texas MD Anderson Cancer Center.

• Trained at MD Anderson – the world's leading cancer center in the United States
• Specializes in PET-CT with Gallium 68(PSMA) for precise prostate cancer staging
• Supervises systemic treatments for complex malignancies and solid tumors
• Uses evidence-based therapies for lung, breast, and gastrointestinal cancers
• Completed a minor specialization in oncology at the Hacettepe University Cancer Institute